药物对比
Erenumab vs Diflunisal
Erenumab（Aimovig）作为CGRP阻滞剂预防偏头痛；Diflunisal（Dolobid）是一种用于关节炎疼痛的NSAID，有黑框警告风险。比较用途和安全性。
此页面暂无可用的对比维度。
临床背景
Patients researching migraine prophylaxis versus NSAID options for chronic pain or arthritis often trigger this comparison.
结论
Erenumab and Diflunisal address different pain mechanisms and neither is universally better.
全部药物对比